Neonatal and perinatal action of BPA at estrogen receptors in pancreatic β-cells results in increased insulin synthesis and release, and increased leptin levels, contributing to the eventual development of insulin resistance and impaired glucose tolerance43–46. The gene discussed is INS; the disease is Insulin resistance.